As a rebellious teenager growing up in the British town of Harpenden, Professor Helen Rees would sneak out to attend anti-apartheid talks. Today, she is a renowned scientist and chair of South Africa’s medicines regulator. Biénne Huisman chatted to Rees about her career, prioritising women’s reproductive health, and her role at the South African Health Products Regulatory Authority.
A potentially life-saving or life-extending breast cancer medicine is available to public sector patients in several of South Africa’s provinces, but not in the Western Cape. Elri Voigt asks what is behind the Western Cape government’s decision.
The worsening climate crisis poses a threat to women and girls and their access to healthcare in the country. Matshidiso Lencoasa argues that although the ongoing climate crisis is daunting, it can serve as an opportunity for budgeting and policy-making processes to centre the most vulnerable and protect women’s right to healthcare.
Mary Selona, a community activist who heads up the Blood River Advice Centre in Limpopo, is putting women at the centre in her quest for social justice. Whether it is intervening when women are refused PrEP at clinics or in more immediate life-threatening situations relating to gender-based violence, Selona is leading from the front. Ufrieda Ho spoke to her as part of Spotlight’s Women in Health series.
The right to abortion has been catapulted into the spotlight by Dobbs v Jackson, the landmark judgment of the United States Supreme Court that overturned Roe v Wade – a 50-year-old precedent of that court that first recognised the constitutional right to abortion in the US. The recognition of a right to abortion is often the first step towards creating an enabling environment for women to access abortions but in some countries in East and Southern Africa, argue the authors, Dobbs may put brakes on little sparks of hope that emerged in recent years.
Dr Daphney Conco is passionate about sexual and reproductive health rights – access to abortion in particular – and that is why she is now at the forefront of research on access to abortion services in South Africa. Tiyese Jeranji spoke to her about her work, her passion for research, and how as a little girl in rural KwaZulu-Natal she dreamed of wearing a graduation gown.
At the start of Women’s month this year, the gang rape of eight women at a mine dump in Krugersdorp made headlines in South Africa and abroad, adding to the country’s blood-curdling statistics of femicide and violence against women. René Sparks argues that the public health sector should play a bigger role in addressing violence against women.
A third or even up to half of women and girls in South Africa aged 15 and older have either experienced physical or sexual intimate partner violence (IPV). Some experts say South Africa almost has a perfect storm of IPV drivers. Elsabé Brits unpacks some of the recent findings published in a landmark Lancet Psychiatry Commission on interpersonal violence and asks experts how we can address this in South Africa.
On 17 February, Deputy Health Minister Dr Sibongiseni Dhlomo led a march against unsafe abortions in Rustenburg, North West, but a march alone cannot eliminate barriers that prevent women and girls from accessing safe abortions in the public health system. Much more is needed, argue Sibusiwe Ndlela, Khanyisa Mapipa and Thokozile Mtsolongo in an open letter.
As we commemorate yet another Women’s Month, we are reminded of the many initiatives that have come and gone in an attempt to address the extreme period poverty that continues to plague South African women and girls. It is time to solve this issue once and for all, and to make sanitary towels and menstrual hygiene products free and readily available, writes René Sparks.
In 1947 the first black woman qualified as a doctor in South Africa. Her name was Mary Malahlela-Xakana. It took the country about 60 years after its first black male doctor started practicing for Malahlela-Xakana to don her stethoscope and practice medicine. Much, but not enough has changed since then, writes Alicestine October.
Early results from a pivotal trial of an HIV prevention injection announced by the University of the Witwatersrand researchers have been hailed as being a “game-changer” to turn “the tide on HIV” as it effectively reduces HIV acquisition and provides women more choices in how to protect themselves. Amy Green reports.
